BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 8374868)

  • 1. TAG-72 (CA 72-4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancer.
    Guadagni F; Roselli M; Cosimelli M; Mannella E; Tedesco M; Cavaliere F; Grassi A; Abbolito MR; Greiner JW; Schlom J
    Cancer; 1993 Oct; 72(7):2098-106. PubMed ID: 8374868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated glycoprotein-72 serum levels complement carcinoembryonic antigen levels in monitoring patients with gastrointestinal carcinoma. A longitudinal study.
    Guadagni F; Roselli M; Amato T; Cosimelli M; Mannella E; Perri P; Abbolito MR; Cavaliere R; Colcher D; Greiner JW
    Cancer; 1991 Dec; 68(11):2443-50. PubMed ID: 1933781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of serum tumor-associated glycoprotein-72 as a novel tumor marker for colorectal cancer patients.
    Guadagni F; Roselli M; Amato T; Cosimelli M; Mannella E; Tedesco M; Grassi A; Casale V; Cavaliere F; Greiner JW
    J Surg Oncol Suppl; 1991; 2():16-20. PubMed ID: 1892526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CA 72-4 measurement of tumor-associated glycoprotein 72 (TAG-72) as a serum marker in the management of gastric carcinoma.
    Guadagni F; Roselli M; Amato T; Cosimelli M; Perri P; Casale V; Carlini M; Santoro E; Cavaliere R; Greiner JW
    Cancer Res; 1992 Mar; 52(5):1222-7. PubMed ID: 1737383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of serum tumor markers in the differential diagnosis between ovarian and colorectal adenocarcinomas.
    Yedema CA; Kenemans P; Wobbes T; Thomas CM; Bon GG; Mulder C; Voorhorst FJ; Verstraeten AA; van Kamp GJ; Hilgers J
    Tumour Biol; 1992; 13(1-2):18-26. PubMed ID: 1589694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of serum CA 19-9 and CEA levels in a population at high risk for colorectal cancer.
    Goldberg EM; Simunovic LM; Drake SL; Mueller WF; Verrill HL
    Hybridoma; 1989 Oct; 8(5):569-75. PubMed ID: 2807313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patients.
    Ohuchi N; Takahashi K; Matoba N; Sato T; Taira Y; Sakai N; Masuda M; Mori S
    Jpn J Clin Oncol; 1989 Sep; 19(3):242-8. PubMed ID: 2810823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Importance of Determining Preoperative Serum Concentration of Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen in Assessing the Progression of Colorectal Cancer.
    Halilovic E; Rasic I; Sofic A; Mujic A; Rovcanin A; Hodzic E; Kulovic E
    Med Arch; 2020 Oct; 74(5):346-349. PubMed ID: 33424087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of CA 72-4 in colorectal carcinoma. Comparison with CEA and CA 19-9.
    Fernández-Fernández L; Tejero E; Tieso A
    Eur J Surg Oncol; 1995 Aug; 21(4):388-90. PubMed ID: 7664904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluation.
    Spila A; Ferroni P; Cosimelli M; D'Alessandro R; Abbolito MR; Mariotti S; Aloe S; Carone MD; Graziano F; Tedesco M; Martini F; Mancini R; Stigliano V; Roselli M; Guadagni F
    Anticancer Res; 2001; 21(2B):1263-70. PubMed ID: 11396197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the value of preoperative serum levels of CA 242 and CEA in the staging and postoperative survival of colorectal adenocarcinoma patients.
    Kim SB; Fernandes LC; Saad SS; Matos D
    Int J Biol Markers; 2003; 18(3):182-7. PubMed ID: 14535588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual cutoff levels of carcinoembryonic antigen and CA 242 indicate recurrence of colorectal cancer with high sensitivity.
    Engarås B
    Dis Colon Rectum; 2003 Mar; 46(3):313-21. PubMed ID: 12626905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal carcinoma liver metastases: clinical significance of preoperative measurement of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels.
    Ishizuka D; Shirai Y; Sakai Y; Hatakeyama K
    Int J Colorectal Dis; 2001 Feb; 16(1):32-7. PubMed ID: 11317695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
    Zhang SY; Lin M; Zhang HB
    Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical usefulness of serum assays of neuron-specific enolase, carcinoembryonic antigen and CA-50 antigen in the diagnosis of lung cancer.
    Bergman B; Brezicka FT; Engström CP; Larsson S
    Eur J Cancer; 1993; 29A(2):198-202. PubMed ID: 8380696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of serum CA 195 and carcinoembryonic antigen in metastatic carcinoma.
    Verdi CJ; Ahmann FR; Schifman RB; Elvick AL; Ahmann ME; Marx PC
    Cancer; 1993 Jun; 71(11):3625-32. PubMed ID: 8490911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CEA, CA 242, CA 19-9, CA 72-4 and hCGbeta in the diagnosis of recurrent colorectal cancer.
    Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Järvinen H; Haglund C
    Tumour Biol; 2004; 25(5-6):228-34. PubMed ID: 15627885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CA 72-4 compared with CEA and CA 19-9 as a marker of some gastrointestinal malignancies.
    Lopez JB; Royan GP; Lakhwani MN; Mahadaven M; Timor J
    Int J Biol Markers; 1999; 14(3):172-7. PubMed ID: 10569140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological studies on CEA, CA 19-9, STn and SLX in colorectal cancer.
    Sato T; Nishimura G; Nonomura A; Miwa K; Miyazaki I
    Hepatogastroenterology; 1999; 46(26):914-9. PubMed ID: 10370638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.